Tissue adhesive coatings for drug coated balloon
AssigneeAbbott Cardiovascular Systems Inc.
InventorsStephen D. Pacetti, John J. Stankus
Life of this patent
Estimating the term…
Abstract
A therapeutic formulation is described for a drug delivery balloon comprising a therapeutic formulation which includes a therapeutic agent and an adhesion additive. The adhesion additive promotes adhesion of the therapeutic formulation a vessel wall of a subject. A system and a method of manufacturing a system including an expandable member having a working length with the therapeutic formulation disposed along at least a portion of the working length is also provided.
Claims43
A system for delivering a therapeutic agent to a vessel wall of a subject, comprising:
- an expandable member having a distal end, a proximal end, and a working length therebetween;
- and
- a therapeutic formulation disposed on at least a portion of the working length of the expandable member, the formulation comprising a therapeutic agent and an adhesion additive, wherein the adhesion additive promotes adhesion of the therapeutic formulation to the vessel wall.
A method for manufacturing a system for delivering a therapeutic agent to a vessel wall of a subject, comprising:
- (a) providing a system comprising an expandable member having a distal end, a proximal end, and a working length therebetween;
- and
- (b) disposing a therapeutic formulation to at least a portion of the working length of the expandable member, wherein the formulation comprises a therapeutic agent and an adhesion additive;
- wherein the adhesion additive promotes adhesion of the therapeutic formulation to the vessel wall.
Dependencies are inferred from the claim text.